Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing... Show more
AMETEK operates a portfolio of more than 40 decentralized niche businesses across two segments: the Electronic Instruments Group (EIG), which supplies analytical, test, and measurement instruments, and the Electromechanical Group (EMG), which provides highly engineered components, interconnects, and specialty metals. The company's market positioning rests on leadership in small, specialized markets where switching costs are high and products carry regulatory or safety mandates.
The core of AMETEK's strategy is its acquisition-driven growth algorithm. By buying differentiated businesses, integrating them, and applying operational discipline, the company has consistently expanded margins while adding new product platforms. Management has indicated capacity to deploy well over $5 billion in capital while maintaining investment-grade ratings, supported by a balance sheet with net debt-to-EBITDA (earnings before interest, taxes, depreciation, and amortization) below 1x. This financial flexibility is a structural advantage in a rising-rate and tariff-distorted environment, though it also makes successful M&A (mergers and acquisitions) execution central to the medium-term outlook.
The most immediate catalyst is the company's November 2026 earnings release. AMETEK enters the print with strong momentum: second-quarter orders rose 28%, the backlog reached a record $4.11 billion, and roughly 80% of that backlog is expected to ship within 12 months, with visibility now extending into 2027. Management raised full-year 2026 guidance to about 10% sales growth and adjusted EPS (earnings per share) of $8.20 to $8.30, above prior consensus.
Beyond earnings, integration of recently completed acquisitions—including Indicor Instrumentation and defense-focused First Aviation Services—will be closely watched. New product vitality remains another catalyst; management has cited roughly 25% new-product vitality as a lever for offsetting inflation and tariffs. On the analyst front, sentiment has firmed through 2026: firms including Bank of America, RBC Capital, Truist, and Mizuho raised price targets following the record second quarter, while Morgan Stanley and Citi maintained more cautious Neutral or Equal-Weight stances at elevated targets. The average price target has trended higher over the past year, signaling a generally more optimistic consensus, though not uniformly so.
AMETEK's trajectory is tightly linked to capital spending in mission-critical infrastructure. Demand in semiconductor manufacturing, power generation and grid infrastructure, aerospace and defense, and medical technology has driven record orders. Management estimates that roughly half of the business is tied to data-center and artificial-intelligence infrastructure, military modernization, commercial aerospace, and power buildout themes—areas expected to benefit from multi-year investment cycles.
At the same time, macro conditions cut both ways. Tariffs and trade disputes pressure input costs and supply chains, and foreign currency fluctuations can dampen reported results for a company with substantial international sales. Interest rates matter primarily through the cost of acquisition financing; AMETEK's strong cash generation and low leverage provide insulation, but a sustained high-rate environment could raise the bar for deal returns. Inflation remains manageable so far, with pricing and productivity gains exceeding cost pressures, but this is a key swing factor for margin sustainability.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, ETF (exchange-traded fund), or other asset may move bullish, bearish, or sideways over the coming week or month. Designed to surface developing trends, potential breakouts, and reversals, the tool lets users explore predictions across a broad range of tradable instruments, with searchable categories, historical context, and alert-oriented functionality. For investors tracking AME alongside broader market shifts, it offers a structured, data-driven way to monitor momentum and timing signals.
For 2026 and beyond, AMETEK's story hinges on whether a cyclical upswing in order activity matures into a durable, structural expansion. Management's guidance implies meaningful earnings growth for 2026, and the record backlog provides near-term revenue visibility. Longer term, the durability of organic growth will depend on sustained semiconductor and defense capital spending, the successful scaling of newer platforms such as Paragon Medical's design wins, and continued success in bolt-on M&A.
Margin sustainability is another focal point. Core operating margins have expanded despite tariffs, helped by pricing, productivity, and roughly 35% to 40% incremental margins. If inflation reaccelerates or tariff exposure intensifies, those gains could compress. Competitive threats also loom in fast-moving precision-instrument and automation markets, while regulatory shifts in aerospace, medical, and environmental markets could reshape demand.
Capital allocation priorities—balanced between acquisitions, opportunistic buybacks, and a growing dividend—will shape long-term shareholder returns. Consensus price targets, which have generally trended higher through 2026, reflect analyst expectations that these structural drivers remain intact, though the wide spread between the lowest and highest targets underscores genuine uncertainty about valuation and execution risk in a maturing industrial cycle.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, AME has been closely correlated with ROP. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if AME jumps, then ROP could also see price increases.
| Ticker / NAME | Correlation To AME | 1D Price Change % |
|---|---|---|
| AME | 100% | +0.33% |
| AME (2 stocks) | 94% Closely correlated | +1.54% |
| Producer Manufacturing (348 stocks) | 15% Poorly correlated | +1.00% |
a manufacturer of electronic instruments and electromechanical devices
Industry IndustrialMachinery
AME may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 23 of 37 cases where AME's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 62%.
The 10-day moving average for AME crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +2.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where AME advanced for three days, in 162 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Aroon Indicator entered an Uptrend today. In 148 of 284 cases where AME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 23 of 63 cases where AME's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 37%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AME as a result. In 36 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 40%.
The Moving Average Convergence Divergence Histogram (MACD) for AME turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 18 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 39%.
AME moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 45%.
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. AME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.925) is normal, around the industry mean (4.069). P/E Ratio (35.264) is within average values for comparable stocks, (37.908). Projected Growth (PEG Ratio) (2.859) is also within normal values, averaging (1.879). Dividend Yield (0.006) settles around the average of (0.031) among similar stocks. P/S Ratio (6.803) is also within normal values, averaging (186.943).